RARA Gene

HGNC Family Zinc fingers
Name retinoic acid receptor, alpha
Description This gene represents a nuclear retinoic acid receptor. The encoded protein, retinoic acid receptor alpha, regulates transcription in a ligand-dependent manner. This gene has been implicated in regulation of development, differentiation, apoptosis, granulopoeisis, and transcription of clock genes. Translocations between this locus and several other loci have been associated with acute promyelocytic leukemia. Alternatively spliced transcript variants have been found for this locus.[provided by RefSeq, Sep 2010]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nRetinoic acid receptor alpha (RARα) is a ligand‐regulated nuclear transcription factor that in its normal state mediates retinoid‐dependent gene expression programs controlling differentiation and proliferation. In the hematopoietic system, its deregulation—most notably via formation of fusion proteins such as PML–RARα and STAT5b–RARα—is a critical driver of acute promyelocytic leukemia (APL). These chimeric proteins act as dominant repressors by altering chromatin structure and silencing key differentiation genes; treatment with all‐trans retinoic acid (ATRA) and arsenic trioxide can trigger their degradation and restore maturation. In addition, RARα dysfunction can be compounded by cooperating genetic lesions and epigenetic modifications that further block differentiation and promote leukemogenesis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "16"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond hematologic malignancies, RARα plays an important role in solid tumors such as breast cancer. In estrogen receptor–positive cancer cells, RARα not only contributes to the classical retinoid transcriptional program but also collaborates with estrogen receptor signaling. Its expression can be induced via intronic regulatory elements and is required for optimal estrogen‐dependent transcription and growth inhibition, underscoring its role in modulating cell proliferation in hormone‐responsive tumors."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "17", "end_ref": "20"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn addition to its well‐established genomic functions, rapid non‐genomic actions of RARα have been documented. Ligand engagement can prompt RARα to associate with components of extra‐nuclear signaling complexes—for example, its interaction with phosphatidylinositol 3-kinase and G protein subunits at membrane lipid rafts facilitates activation of kinase cascades (including p38 MAPK). Moreover, cAMP‐dependent phosphorylation events modulate RARα function and enhance its DNA binding, linking second messenger signaling to retinoid responses."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "21", "end_ref": "23"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nRARα activity is finely tuned by a host of coregulators and post‐translational modifications. Coactivators such as ASXL1 (which cooperates with SRC-1) enhance RARα transcriptional activity, whereas corepressors and structural rearrangements in the receptor underpin its basal repressive state in the absence of ligand. The recruitment of factors such as TopoIIβ further modulates its function, delineating complex regulatory networks that are vital in both normal physiology and in the aberrant transcriptional repression observed with fusion oncoproteins."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "24", "end_ref": "27"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nOther studies have implicated RARα in diverse disease contexts. In neurodegenerative settings, microRNAs such as miR-138 target RARα, thereby modulating kinase pathways (eg, GSK-3β) and contributing to tau hyperphosphorylation. In viral infections, RARα regulates the expression of host cell receptors such as NTCP, impacting hepatitis B virus entry. Moreover, aberrant RARα expression has been linked to cancer stem cell features in multiple myeloma, while viral proteins (eg, from hepatitis C) can modulate its transcriptional activity."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "28", "end_ref": "33"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMutations and structural alterations affecting RARα, including those present in fusion oncoproteins, underlie resistance to differentiation therapies such as ATRA and arsenic trioxide. Specific point mutations and alterations in the recruitment of corepressors (or shifts in coactivator interactions) can hamper ligand-induced degradation of the oncoprotein, thereby contributing to therapeutic resistance. Such molecular insights are crucial for understanding variable responses in diseases like APL and for developing strategies to overcome retinoid resistance."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "34", "end_ref": "37"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFinally, recent work has highlighted additional roles for RARα in the regulation of noncoding elements. For example, its activation of specific DR2 Alu repeats in embryonic stem cells underscores a mechanism by which RARα influences the decay of stem cell mRNAs and fosters differentiation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "38"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "L Z He, M Bhaumik, C Tribioli, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Two critical hits for promyelocytic leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2000)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s1097-2765(00)00111-8"}], "href": "https://doi.org/10.1016/s1097-2765(00"}, {"type": "t", "text": "00111-8) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11106752"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11106752"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Sutisak Kitareewan, Ian Pitha-Rowe, David Sekula, et al. "}, {"type": "b", "children": [{"type": "t", "text": "UBE1L is a retinoid target that triggers PML/RARalpha degradation and apoptosis in acute promyelocytic leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.052011299"}], "href": "https://doi.org/10.1073/pnas.052011299"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11891284"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11891284"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Shuo Dong, David J Tweardy "}, {"type": "b", "children": [{"type": "t", "text": "Interactions of STAT5b-RARalpha, a novel acute promyelocytic leukemia fusion protein, with retinoic acid receptor and STAT3 signaling pathways."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood.v99.8.2637"}], "href": "https://doi.org/10.1182/blood.v99.8.2637"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11929748"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11929748"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Louise M Kelly, Jeffrey L Kutok, Ifor R Williams, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.122233699"}], "href": "https://doi.org/10.1073/pnas.122233699"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12060771"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12060771"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Matthew J Walter, John S Park, Rhonda E Ries, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reduced PU.1 expression causes myeloid progenitor expansion and increased leukemia penetrance in mice expressing PML-RARalpha."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0504247102"}], "href": "https://doi.org/10.1073/pnas.0504247102"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16113082"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16113082"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Francesco Fazi, Giuseppe Zardo, Vania Gelmetti, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Heterochromatic gene repression of the retinoic acid pathway in acute myeloid leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2006-09-045781"}], "href": "https://doi.org/10.1182/blood-2006-09-045781"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17244680"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17244680"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Claudia Hoemme, Abdul Peerzada, Gerhard Behre, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Chromatin modifications induced by PML-RARalpha repress critical targets in leukemogenesis as analyzed by ChIP-Chip."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2007-03-079921"}], "href": "https://doi.org/10.1182/blood-2007-03-079921"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18024792"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18024792"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Rihab Nasr, Marie-Claude Guillemin, Omar Ferhi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Med (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nm.1891"}], "href": "https://doi.org/10.1038/nm.1891"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19029980"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19029980"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "S Wojiski, F C Guibal, T Kindler, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PML-RARalpha initiates leukemia by conferring properties of self-renewal to committed promyelocytic progenitors."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Leukemia (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/leu.2009.63"}], "href": "https://doi.org/10.1038/leu.2009.63"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19322209"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19322209"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Joost H A Martens, Arie B Brinkman, Femke Simmer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "PML-RARalpha/RXR Alters the Epigenetic Landscape in Acute Promyelocytic Leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Cell (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ccr.2009.12.042"}], "href": "https://doi.org/10.1016/j.ccr.2009.12.042"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20159609"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20159609"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Pauline Isakson, Magnar Bjørås, Stig Ove Bøe, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Autophagy contributes to therapy-induced degradation of the PML/RARA oncoprotein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2010-01-261040"}], "href": "https://doi.org/10.1182/blood-2010-01-261040"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20574048"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20574048"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Yukiya Yamamoto, Sachiko Tsuzuki, Motohiro Tsuzuki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2010-01-264432"}], "href": "https://doi.org/10.1182/blood-2010-01-264432"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20807888"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20807888"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Roberta Carbone, Oronza A Botrugno, Simona Ronzoni, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Recruitment of the histone methyltransferase SUV39H1 and its role in the oncogenic properties of the leukemia-associated PML-retinoic acid receptor fusion protein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.26.4.1288-1296.2006"}], "href": "https://doi.org/10.1128/MCB.26.4.1288-1296.2006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16449642"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16449642"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Maaike Luesink, Jeroen L A Pennings, Willemijn M Wissink, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Chemokine induction by all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia: triggering the differentiation syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2009-02-204834"}], "href": "https://doi.org/10.1182/blood-2009-02-204834"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19828696"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19828696"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Paul A O'Connell, Patricia A Madureira, Jason N Berman, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of S100A10 by the PML-RAR-α oncoprotein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2010-07-298851"}], "href": "https://doi.org/10.1182/blood-2010-07-298851"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21310922"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21310922"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Fabien Guidez, Sarah Parks, Henna Wong, et al. "}, {"type": "b", "children": [{"type": "t", "text": "RARalpha-PLZF overcomes PLZF-mediated repression of CRABPI, contributing to retinoid resistance in t(11;17) acute promyelocytic leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0704433104"}], "href": "https://doi.org/10.1073/pnas.0704433104"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18000064"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18000064"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Caryn S Ross-Innes, Rory Stark, Kelly A Holmes, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Dev (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1101/gad.552910"}], "href": "https://doi.org/10.1101/gad.552910"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20080953"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20080953"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Sujun Hua, Ralf Kittler, Kevin P White "}, {"type": "b", "children": [{"type": "t", "text": "Genomic antagonism between retinoic acid and estrogen signaling in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cell.2009.04.043"}], "href": "https://doi.org/10.1016/j.cell.2009.04.043"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19563758"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19563758"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Josée Laganière, Geneviève Deblois, Vincent Giguère "}, {"type": "b", "children": [{"type": "t", "text": "Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Endocrinol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/me.2005-0040"}], "href": "https://doi.org/10.1210/me.2005-0040"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15831516"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15831516"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Min Lu, Rafael Mira-y-Lopez, Shigeo Nakajo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of estrogen receptor alpha, retinoic acid receptor alpha and cellular retinoic acid binding protein II genes is coordinately regulated in human breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.onc.1208661"}], "href": "https://doi.org/10.1038/sj.onc.1208661"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15870697"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15870697"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Susana Masiá, Susana Alvarez, Angel R de Lera, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Rapid, nongenomic actions of retinoic acid on phosphatidylinositol-3-kinase signaling pathway mediated by the retinoic acid receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Endocrinol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/me.2007-0062"}], "href": "https://doi.org/10.1210/me.2007-0062"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17595318"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17595318"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Emilie Gaillard, Nathalie Bruck, Yann Brelivet, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Phosphorylation by PKA potentiates retinoic acid receptor alpha activity by means of increasing interaction with and phosphorylation by cyclin H/cdk7."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0509717103"}], "href": "https://doi.org/10.1073/pnas.0509717103"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16769902"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16769902"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "A Piskunov, C Rochette-Egly "}, {"type": "b", "children": [{"type": "t", "text": "A retinoic acid receptor RARα pool present in membrane lipid rafts forms complexes with G protein αQ to activate p38MAPK."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2011.499"}], "href": "https://doi.org/10.1038/onc.2011.499"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22056876"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22056876"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Yang-Sook Cho, Eun-Joo Kim, Ui-Hyun Park, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Additional sex comb-like 1 (ASXL1), in cooperation with SRC-1, acts as a ligand-dependent coactivator for retinoic acid receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M512616200"}], "href": "https://doi.org/10.1074/jbc.M512616200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16606617"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16606617"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Albane le Maire, Catherine Teyssier, Cathie Erb, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A unique secondary-structure switch controls constitutive gene repression by retinoic acid receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Struct Mol Biol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nsmb.1855"}], "href": "https://doi.org/10.1038/nsmb.1855"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20543827"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20543827"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Raffaella Villa, Lluis Morey, Veronica A Raker, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The methyl-CpG binding protein MBD1 is required for PML-RARalpha function."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0509343103"}], "href": "https://doi.org/10.1073/pnas.0509343103"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16432238"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16432238"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Suzan McNamara, Hongling Wang, Nessrine Hanna, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Topoisomerase IIbeta negatively modulates retinoic acid receptor alpha function: a novel mechanism of retinoic acid resistance."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.01576-07"}], "href": "https://doi.org/10.1128/MCB.01576-07"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18212063"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18212063"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Xiong Wang, Lu Tan, Yanjun Lu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-138 promotes tau phosphorylation by targeting retinoic acid receptor alpha."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2015.02.001"}], "href": "https://doi.org/10.1016/j.febslet.2015.02.001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25680531"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25680531"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Inna G Ovsyannikova, Neelam Dhiman, Iana H Haralambieva, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Genet (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00439-009-0763-1"}], "href": "https://doi.org/10.1007/s00439-009-0763-1"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19902255"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19902255"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Koichi Watashi, Makoto Hijikata, Ayako Tagawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Modulation of retinoid signaling by a cytoplasmic viral protein via sequestration of Sp110b, a potent transcriptional corepressor of retinoic acid receptor, from the nucleus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell Biol (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/MCB.23.21.7498-7509.2003"}], "href": "https://doi.org/10.1128/MCB.23.21.7498-7509.2003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14559998"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14559998"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Senko Tsukuda, Koichi Watashi, Masashi Iwamoto, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dysregulation of retinoic acid receptor diminishes hepatocyte permissiveness to hepatitis B virus infection through modulation of sodium taurocholate cotransporting polypeptide (NTCP) expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M114.602540"}], "href": "https://doi.org/10.1074/jbc.M114.602540"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25550158"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25550158"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Henrik J Johansson, Betzabe C Sanchez, Filip Mundt, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncomms3175"}], "href": "https://doi.org/10.1038/ncomms3175"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23868472"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23868472"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Krishna K Ratnam, Xiaobei Feng, Peter Y Chuang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Role of the retinoic acid receptor-α in HIV-associated nephropathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Kidney Int (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ki.2010.470"}], "href": "https://doi.org/10.1038/ki.2010.470"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21150871"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21150871"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Emi Goto, Akihiro Tomita, Fumihiko Hayakawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Missense mutations in PML-RARA are critical for the lack of responsiveness to arsenic trioxide treatment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Blood (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1182/blood-2011-01-329433"}], "href": "https://doi.org/10.1182/blood-2011-01-329433"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21613260"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21613260"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Takemi Tanaka, Kwang S Suh, Angela M Lo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "p21WAF1/CIP1 is a common transcriptional target of retinoid receptors: pleiotropic regulatory mechanism through retinoic acid receptor (RAR)/retinoid X receptor (RXR) heterodimer and RXR/RXR homodimer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M701700200"}], "href": "https://doi.org/10.1074/jbc.M701700200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17656367"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17656367"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Harry D Dawson, Gary Collins, Robert Pyle, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The Retinoic Acid Receptor-alpha mediates human T-cell activation and Th2 cytokine and chemokine production."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Immunol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1471-2172-9-16"}], "href": "https://doi.org/10.1186/1471-2172-9-16"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18416830"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18416830"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Tonia C Carter, Anne M Molloy, Faith Pangilinan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Testing reported associations of genetic risk factors for oral clefts in a large Irish study population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Birth Defects Res A Clin Mol Teratol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/bdra.20639"}], "href": "https://doi.org/10.1002/bdra.20639"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19937600"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19937600"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "QiDong Hu, Bogdan Tanasa, Michele Trabucchi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "DICER- and AGO3-dependent generation of retinoic acid-induced DR2 Alu RNAs regulates human stem cell proliferation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Struct Mol Biol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nsmb.2400"}], "href": "https://doi.org/10.1038/nsmb.2400"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23064648"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23064648"}]}]}]}
Synonyms NR1B1, RAR
Proteins RARA_HUMAN
NCBI Gene ID 5914
API
Download Associations
Predicted Functions View RARA's ARCHS4 Predicted Functions.
Co-expressed Genes View RARA's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View RARA's ARCHS4 Predicted Functions.

Functional Associations

RARA has 10,560 functional associations with biological entities spanning 8 categories (molecular profile, organism, functional term, phrase or reference, chemical, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 136 datasets.

Click the + buttons to view associations for RARA from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
Achilles Cell Line Gene Essentiality Profiles cell lines with fitness changed by RARA gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset.
Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles tissues with high or low expression of RARA gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles tissues with high or low expression of RARA gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset.
Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles tissue samples with high or low expression of RARA gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray tissue samples with high or low expression of RARA gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset.
Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq tissue samples with high or low expression of RARA gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset.
Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles tissues with high or low expression of RARA gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset.
Biocarta Pathways pathways involving RARA protein from the Biocarta Pathways dataset.
BioGPS Cell Line Gene Expression Profiles cell lines with high or low expression of RARA gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset.
BioGPS Human Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of RARA gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset.
BioGPS Mouse Cell Type and Tissue Gene Expression Profiles cell types and tissues with high or low expression of RARA gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset.
Carcinogenome Chemical Perturbation Carcinogenicity Signatures small molecule perturbations changing expression of RARA gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset.
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of RARA gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
CCLE Cell Line Gene Expression Profiles cell lines with high or low expression of RARA gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset.
CCLE Cell Line Gene Mutation Profiles cell lines with RARA gene mutations from the CCLE Cell Line Gene Mutation Profiles dataset.
CellMarker Gene-Cell Type Associations cell types associated with RARA gene from the CellMarker Gene-Cell Type Associations dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of RARA gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of RARA gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
ChEA Transcription Factor Targets 2022 transcription factors binding the promoter of RARA gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset.
CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of RARA gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores cellular components containing RARA protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset.
COMPARTMENTS Curated Protein Localization Evidence Scores 2025 cellular components containing RARA protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 cellular components containing RARA protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores 2025 dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores cellular components co-occuring with RARA protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 cellular components co-occuring with RARA protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset.
CORUM Protein Complexes protein complexs containing RARA protein from the CORUM Protein Complexes dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of RARA gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
COSMIC Cell Line Gene Mutation Profiles cell lines with RARA gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset.
CTD Gene-Chemical Interactions chemicals interacting with RARA gene/protein from the curated CTD Gene-Chemical Interactions dataset.
CTD Gene-Disease Associations diseases associated with RARA gene/protein from the curated CTD Gene-Disease Associations dataset.
DeepCoverMOA Drug Mechanisms of Action small molecule perturbations with high or low expression of RARA protein relative to other small molecule perturbations from the DeepCoverMOA Drug Mechanisms of Action dataset.
DepMap CRISPR Gene Dependency cell lines with fitness changed by RARA gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset.
DISEASES Curated Gene-Disease Association Evidence Scores diseases involving RARA gene from the DISEASES Curated Gene-Disease Assocation Evidence Scores dataset.
DISEASES Curated Gene-Disease Association Evidence Scores 2025 diseases involving RARA gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores diseases co-occuring with RARA gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.
DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 diseases co-occuring with RARA gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset.
DisGeNET Gene-Disease Associations diseases associated with RARA gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset.
DisGeNET Gene-Phenotype Associations phenotypes associated with RARA gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset.
DrugBank Drug Targets interacting drugs for RARA protein from the curated DrugBank Drug Targets dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at RARA gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of RARA gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of RARA gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
ESCAPE Omics Signatures of Genes and Proteins for Stem Cells PubMedIDs of publications reporting gene signatures containing RARA from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset.
GAD Gene-Disease Associations diseases associated with RARA gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.
GAD High Level Gene-Disease Associations diseases associated with RARA gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset.
GDSC Cell Line Gene Expression Profiles cell lines with high or low expression of RARA gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with RARA gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing RARA from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Diseases disease perturbations changing expression of RARA gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of RARA gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Kinase Perturbations kinase perturbations changing expression of RARA gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of RARA gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations transcription factor perturbations changing expression of RARA gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Viral Infections virus perturbations changing expression of RARA gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset.
GO Biological Process Annotations 2015 biological processes involving RARA gene from the curated GO Biological Process Annotations 2015 dataset.
GO Biological Process Annotations 2023 biological processes involving RARA gene from the curated GO Biological Process Annotations 2023 dataset.
GO Biological Process Annotations 2025 biological processes involving RARA gene from the curated GO Biological Process Annotations2025 dataset.
GO Cellular Component Annotations 2015 cellular components containing RARA protein from the curated GO Cellular Component Annotations 2015 dataset.
GO Cellular Component Annotations 2023 cellular components containing RARA protein from the curated GO Cellular Component Annotations 2023 dataset.
GO Cellular Component Annotations 2025 cellular components containing RARA protein from the curated GO Cellular Component Annotations 2025 dataset.
GO Molecular Function Annotations 2015 molecular functions performed by RARA gene from the curated GO Molecular Function Annotations 2015 dataset.
GO Molecular Function Annotations 2023 molecular functions performed by RARA gene from the curated GO Molecular Function Annotations 2023 dataset.
GO Molecular Function Annotations 2025 molecular functions performed by RARA gene from the curated GO Molecular Function Annotations 2025 dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of RARA gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
GTEx Tissue Gene Expression Profiles 2023 tissues with high or low expression of RARA gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset.
GTEx Tissue Sample Gene Expression Profiles tissue samples with high or low expression of RARA gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset.
Guide to Pharmacology Chemical Ligands of Receptors ligands (chemical) binding RARA receptor from the curated Guide to Pharmacology Chemical Ligands of Receptors dataset.
GWAS Catalog SNP-Phenotype Associations 2025 phenotypes associated with RARA gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset.
Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles cell lines with high or low expression of RARA gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset.
HMDB Metabolites of Enzymes interacting metabolites for RARA protein from the curated HMDB Metabolites of Enzymes dataset.
HPA Cell Line Gene Expression Profiles cell lines with high or low expression of RARA gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset.
HPA Tissue Gene Expression Profiles tissues with high or low expression of RARA gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset.
HPA Tissue Sample Gene Expression Profiles tissue samples with high or low expression of RARA gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset.
HPO Gene-Disease Associations phenotypes associated with RARA gene by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset.
Hub Proteins Protein-Protein Interactions interacting hub proteins for RARA from the curated Hub Proteins Protein-Protein Interactions dataset.
HuBMAP ASCT+B Annotations cell types associated with RARA gene from the HuBMAP ASCT+B dataset.
HuBMAP ASCT+B Augmented with RNA-seq Coexpression cell types associated with RARA gene from the HuBMAP ASCT+B Augmented with RNA-seq Coexpression dataset.
HuGE Navigator Gene-Phenotype Associations phenotypes associated with RARA gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.
InterPro Predicted Protein Domain Annotations protein domains predicted for RARA protein from the InterPro Predicted Protein Domain Annotations dataset.
JASPAR Predicted Human Transcription Factor Targets 2025 transcription factors regulating expression of RARA gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset.
JASPAR Predicted Mouse Transcription Factor Targets 2025 transcription factors regulating expression of RARA gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of RARA gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
KEA Substrates of Kinases kinases that phosphorylate RARA protein from the curated KEA Substrates of Kinases dataset.
KEGG Pathways pathways involving RARA protein from the KEGG Pathways dataset.
KEGG Pathways 2026 pathways involving RARA protein from the KEGG Pathways 2026 dataset.
Kinase Library Serine Threonine Kinome Atlas kinases that phosphorylate RARA protein from the Kinase Library Serine Threonine Atlas dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of RARA gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles cell lines with high or low expression of RARA gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles cell lines with RARA gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of RARA gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
LINCS L1000 CMAP Chemical Perturbation Consensus Signatures small molecule perturbations changing expression of RARA gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset.
LINCS L1000 CMAP CRISPR Knockout Consensus Signatures gene perturbations changing expression of RARA gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset.
LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of RARA gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
LOCATE Curated Protein Localization Annotations cellular components containing RARA protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset.
LOCATE Predicted Protein Localization Annotations cellular components predicted to contain RARA protein from the LOCATE Predicted Protein Localization Annotations dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by RARA gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
MiRTarBase microRNA Targets microRNAs targeting RARA gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of RARA gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
MoTrPAC Rat Endurance Exercise Training tissue samples with high or low expression of RARA gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset.
MPO Gene-Phenotype Associations phenotypes of transgenic mice caused by RARA gene mutations from the MPO Gene-Phenotype Associations dataset.
MSigDB Cancer Gene Co-expression Modules co-expressed genes for RARA from the MSigDB Cancer Gene Co-expression Modules dataset.
MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations gene perturbations changing expression of RARA gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset.
NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles drug perturbations changing expression of RARA gene from the NIBR DRUG-seq U2OS MoA Box dataset.
OMIM Gene-Disease Associations phenotypes associated with RARA gene from the curated OMIM Gene-Disease Associations dataset.
Pathway Commons Protein-Protein Interactions interacting proteins for RARA from the Pathway Commons Protein-Protein Interactions dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of RARA gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations gene perturbations changing expression of RARA gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
PFOCR Pathway Figure Associations 2023 pathways involving RARA protein from the PFOCR Pathway Figure Associations 2023 dataset.
PFOCR Pathway Figure Associations 2024 pathways involving RARA protein from the Wikipathways PFOCR 2024 dataset.
Phosphosite Textmining Biological Term Annotations biological terms co-occuring with RARA protein in abstracts of publications describing phosphosites from the Phosphosite Textmining Biological Term Annotations dataset.
PhosphoSitePlus Phosphosite-Disease Associations diseases associated with RARA protein from the curated PhosphoSitePlus Phosphosite-Disease Associations dataset.
PhosphoSitePlus Substrates of Kinases kinases that phosphorylate RARA protein from the curated PhosphoSitePlus Substrates of Kinases dataset.
PID Pathways pathways involving RARA protein from the PID Pathways dataset.
Reactome Pathways 2014 pathways involving RARA protein from the Reactome Pathways dataset.
Reactome Pathways 2024 pathways involving RARA protein from the Reactome Pathways 2024 dataset.
Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures gene perturbations changing expression of RARA gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset.
Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles cell types and tissues with high or low DNA methylation of RARA gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset.
Roadmap Epigenomics Cell and Tissue Gene Expression Profiles cell types and tissues with high or low expression of RARA gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at RARA gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
RummaGEO Drug Perturbation Signatures drug perturbations changing expression of RARA gene from the RummaGEO Drug Perturbation Signatures dataset.
RummaGEO Gene Perturbation Signatures gene perturbations changing expression of RARA gene from the RummaGEO Gene Perturbation Signatures dataset.
Sci-Plex Drug Perturbation Signatures drug perturbations changing expression of RARA gene from the Sci-Plex Drug Perturbation Signatures dataset.
SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Protein Ligands ligand (protein) perturbations changing phosphorylation of RARA protein from the SILAC Phosphoproteomics Signatures of Differentially Phosphorylated Proteins for Protein Ligands dataset.
Tabula Sapiens Gene-Cell Associations cell types with high or low expression of RARA gene relative to other cell types from the Tabula Sapiens Gene-Cell Associations dataset.
Tahoe Therapeutics Tahoe 100M Perturbation Atlas drug perturbations changing expression of RARA gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
TargetScan Predicted Conserved microRNA Targets microRNAs regulating expression of RARA gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset.
TargetScan Predicted Nonconserved microRNA Targets microRNAs regulating expression of RARA gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset.
TCGA Signatures of Differentially Expressed Genes for Tumors tissue samples with high or low expression of RARA gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores tissues with high expression of RARA protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset.
TISSUES Curated Tissue Protein Expression Evidence Scores 2025 tissues with high expression of RARA protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores tissues with high expression of RARA protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset.
TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 tissues with high expression of RARA protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores tissues co-occuring with RARA protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset.
TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 tissues co-occuring with RARA protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset.
WikiPathways Pathways 2014 pathways involving RARA protein from the Wikipathways Pathways 2014 dataset.
WikiPathways Pathways 2024 pathways involving RARA protein from the WikiPathways Pathways 2024 dataset.